drugset / Trial / NCT01108003
Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Terminated
7 enrolled
Roswell Park Cancer Institute
Johns Hopkins University · collabNational Cancer Institute (NCI) · collab
RandomizedSingle-groupOpen-labelTreatment
Summary
Rationale: Broccoli sprout extract contains ingredients that may prevent or slow the growth of certain cancers. Purpose: This pilot study is studying the side effects of broccoli sprout extract in treating patients with transitional cell bladder cancer undergoing surgery.
Timeline
- Start
- 2010-04
- Primary completion
- 2014-09
- Completion
- 2015-10
Outcome
Outcome not reported
Stopped (Enrollment): “low accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | broccoli sprout extract | Unknown | 0.2 mmol | Oral |